VTE Prophylaxis in Ventilated Patients

Introduction to VTE Prophylaxis

• The American College of Chest Physicians recommends that ventilated patients receive pharmacologic VTE prophylaxis with subcutaneous low-dose unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) unless bleeding risk outweighs the benefits 1, 2

Route of Administration

• Subcutaneous administration is the standard route for VTE prophylaxis in critically ill and ventilated patients 1, 2
• Low-dose subcutaneous UFH (5,000 IU three times daily) or LMWH (e.g., enoxaparin 40 mg once daily) are the recommended prophylactic regimens 1, 2

Specific Recommendations for Critically Ill/Ventilated Patients

• The Society of Critical Care Medicine prefers LMWH over UFH for VTE prophylaxis in critically ill patients when no contraindications exist 2, 3
• For patients with severe renal impairment, UFH is preferred over LMWH due to renal metabolism concerns 1, 2

Duration and Timing

• Prophylaxis should be continued throughout the period of immobilization or acute hospital stay 1, 5
• The American College of Chest Physicians recommends continuing prophylaxis throughout the period of immobilization or acute hospital stay 1

Combination Approach for High-Risk Patients

• Mechanical prophylaxis (intermittent pneumatic compression) should be added to pharmacologic prophylaxis whenever possible in critically ill patients 2, 3
• Graduated compression stockings are not recommended as sole prophylaxis 6, 7

When to Avoid Pharmacologic Prophylaxis

• Active bleeding is an absolute contraindication for pharmacologic prophylaxis 4
• Severe thrombocytopenia contraindicates heparin use 4
• Recent intracranial hemorrhage requires mechanical prophylaxis only 4

Risk Assessment Framework

• VTE risk factors in ventilated patients include immobilization, sepsis or septic shock, advanced age, active cancer, history of prior VTE, central venous catheters, and obesity 2, 5, 8
• Bleeding risk factors include active bleeding or recent hemorrhage, severe thrombocytopenia, coagulopathy, recent neurosurgery or intracranial hemorrhage, and severe liver disease 2, 4, 5, 8, 9